Unexpectedly, we found that in A549 lung cancer cell line the drug combination A + N induced the expression of several elements of a signaling pathway encompassing TREM2 (a receptor), TYROBP (a co-receptor), SYK (a kinase) and BLNK (an adaptor protein) [3]. This evidence concerns the gene BLNK and lung cancer.